Search - tctmd.com

Displaying 181 - 200 of 248

Sort: Relevancy | Date

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Rui Campante Teles

September 15, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Pedro Canas da Silva

September 15, 2014

Presentation TCT 2014

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Rui Campante Teles

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Daily News

Review: Some Cardiac MRI Findings Help Risk-Stratify CAD Patients

January 29, 2014

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

News Industry News

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

October 31, 2013

News Industry News

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

October 31, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

L.A. McKeown

October 11, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

Presentation SOLACI 2013

5-Years Results From the Brazilian TAVI Registry

Presenter: F?bio S. Brito Jr.

July 26, 2013

Presentation SOLACI 2013

TAVI in the Real World Session: Does the Brazilian Experience Resemble Worldwide Results?

Presenter: Rog?rio Sarmento-Leite

July 25, 2013

Presentation SOLACI 2013

Insights From the Brazilian TAVI Registry

Presenter: F?bio S. Brito Jr.

July 24, 2013

Advertisement

How Did I Treat This Case?

How Would I Treat This Case?

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Elixir Medical Announces Schedule of Programs for TCT 2014

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

Review: Some Cardiac MRI Findings Help Risk-Stratify CAD Patients

OPTIMIZE: 3-Month DAPT Safe with ZES

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

5-Years Results From the Brazilian TAVI Registry

TAVI in the Real World Session: Does the Brazilian Experience Resemble Worldwide Results?

Insights From the Brazilian TAVI Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content